SIRT1 and inflammatory bowel disease: By supplementing NAD + precursors or activating the Sirtuin 1 (SIRT1)/AMPK pathway, mitochondrial biogenesis and antioxidant capacity can be synergistically enhanced, correcting immune-metabolic imbalance in both directions and providing an additional molecular target for IBD intervention [458, 459].